Início › Atrofia Muscular Espinhal › Texas
Ensaios clínicos de Atrofia Muscular Espinhal em Texas
10 estudos para Atrofia Muscular Espinhal estão buscando participantes em locais em Texas.
Cidades em Texas
Texto oficial do estudo (Inglês)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
- The University of Texas Southwestern Medical Center at Dallas, Dallas
- Cook Children's Jane and John Justin Neurosciences Center, Fort Worth
RecrutandoFase 4
3 Months – 24 Months · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05861986A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
- University of Texas Southwestern Medical Center, Dallas
- Neurology Rare Disease Center, Flower Mound
- Cook Children's Medical Center, Fort Worth
- e mais 1
RecrutandoFase 2
Até 2 anos · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07047144A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
- Neurology Rare Disease Center, Flower Mound
- Texas Children's Hospital, Houston
RecrutandoFase 2
Idades de 5 a 17 · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07287982A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
- University of Texas Southwestern Medical Center, Dallas
RecrutandoFase 4
3 Months – 24 Months · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT05861999A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
- Texas Childrens Hospital Houston, Houston
RecrutandoFase 1
Idades 3 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06555419Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
- Texas Children's Hospital, Houston
Recrutando
Idades 3 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT05866419A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
- Neurology Rare Disease Center, Flower Mound
RecrutandoFase 3
0 Days – 42 Days · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07221669A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
- Neurology Rare Disease Center, Flower Mound
RecrutandoFase 3
0 Days – 7 Months · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT07444450Clinical Procedures to Support Research in ALS
- University of Texas San Antonio Health Science Center, San Antonio
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 15 de jun. de 2026 · NCT03489278Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
- Cook Children's, Fort Worth
- Texas Children's Hospital, Houston
- CHRISTUS Health, San Antonio
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 31 de jan. de 2025 · NCT04174157Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.